A police officer asks you to stand on one leg, follow a pen with your eyes, and count backwards. Hours later, in a windowless room at the station, a second officer wearing a Drug Recognition Expert badge takes your pulse three times, checks your pupil size against a card, and writes a one-paragraph opinion that you were impaired by cannabis. Prosecutors then walk that opinion into court as expert testimony.
In 2026, that walk is getting shorter. The National Highway Traffic Safety Administration has conceded in writing that blood THC levels do not correlate cleanly with driving impairment. A North Carolina appellate court has held that even a certified DRE must satisfy the trial court's reliability gatekeeping under Rule 702. A Florida appellate court has held that the smell of marijuana alone no longer supplies probable cause. And the Drug Enforcement Administration has moved FDA-approved and state-licensed medical marijuana to Schedule III, with a broader rescheduling hearing running through mid-July 2026.
The combination has produced something rare in DUI practice: an actual gatekeeping moment. Trial judges who used to wave DRE testimony in under a recitation of the officer's certification are now being asked, on the record, whether the 12-step protocol is reliable science as applied to cannabis. Defense lawyers who file the right motion at the right time are getting answers they did not expect to get.
What the DRE Protocol Actually Is
The Drug Recognition Expert program is administered by the International Association of Chiefs of Police. Its centerpiece is a 12-step evaluation that a certified officer is supposed to perform on a suspect after a vehicle stop and arrest. The steps include a breath alcohol test, an interview with the arresting officer, a preliminary examination with three pulse readings, eye examinations, divided attention tests that overlap with the standardized field sobriety battery, vital signs, a darkroom pupil examination, muscle tone and injection site checks, suspect statements, the DRE's opinion as to the category of drug causing impairment, and a toxicology specimen. The institutional description of the 12 steps is published by the IACP itself.
The protocol sits on top of the Standardized Field Sobriety Test battery. That battery was developed and validated for alcohol impairment, not cannabis. The North Carolina Office of Indigent Defense Services maintains a defense-oriented overview of the DRE methodology that lays out both the protocol and the foundational validation studies on which it rests: Bigelow in 1985, Compton in 1986, and Adler in 1994. Those studies have been criticized for methodological flaws, including lack of blinding and reliance on suspects who were already arrested and therefore presumed impaired before the DRE walked into the room.
The DRE program's institutional credibility comes from training hours and certification cards, not from peer-reviewed validation of the categorical opinion the DRE is asked to render. That gap is the entire defense argument.
NHTSA Has Already Conceded the Science
The single most powerful document a defense lawyer can put in front of a judge in a cannabis DUI case is the federal government's own report. In July 2017, NHTSA delivered Marijuana-Impaired Driving: A Report to Congress (DOT HS 812 440). The report states that the poor correlation of THC concentrations in the blood with impairment means setting per se levels is not meaningful. NHTSA's own researchers also reported that peak cannabis impairment occurs roughly 90 minutes after smoking, by which point blood THC has already declined more than 80 percent from peak.
The timing problem is fatal to most roadside cases. A driver stopped on the side of a highway, transported to a station, evaluated by a DRE, and then taken for a blood draw is producing a toxicology number that has no fixed relationship to the moment of driving. NHTSA itself has acknowledged that the SFSTs were validated for alcohol, not cannabis. Placebo-controlled studies show the SFST battery is only weakly sensitive to cannabis impairment, especially in tolerant users. More recent research in Traffic Injury Prevention has proposed add-on tasks like finger-to-nose and modified Romberg observations, which is itself an admission that the existing battery is not enough.
Criminal Legal News synthesized the 2025 scientific critique and reached the same conclusion the defense bar has been arguing for years: the science of cannabis impairment detection is not where the prosecution theory of these cases assumes it is.
State v. Moore and the 2025 Rule 702 Inflection
On July 16, 2025, the North Carolina Court of Appeals decided State v. Moore, 2025-NCCOA-467. The University of North Carolina School of Government's Criminal Law Blog provided the authoritative legal analysis in a September 3, 2025 post. The holding is the one defense attorneys across the country have been waiting for. Even a properly certified DRE must satisfy Rule 702(a)(3): the witness must have applied the principles and methods reliably to the facts of the case. Testimony based on video review two years after the stop, without a live DRE examination of the defendant, does not satisfy that requirement.
The Moore court ultimately concluded the error was harmless on the facts of that case. That is not how defense lawyers outside North Carolina are using it. North Carolina Lawyers Weekly wrote up the decision in August 2025 as a watershed moment for DRE qualification. Practitioners are citing Moore by analogy in jurisdictions that have adopted versions of Federal Rule of Evidence 702, which is nearly all of them, for the proposition that DRE testimony is not self-authenticating. The methodology has to be applied. Personally. To this defendant. By this DRE.
The video-only DRE problem is especially common in cases where the original DRE has retired, transferred, or is otherwise unavailable. Prosecutors have sometimes tried to plug the gap with a different officer reviewing the dashcam and bodycam. After Moore, that move is fragile.
Williams v. State and the Collapse of Odor-Only Probable Cause
On October 1, 2025, Florida's Second District Court of Appeal decided Williams v. State. As documented in the practitioner press, the court held that the odor of marijuana alone no longer establishes probable cause in a state where hemp is legal and medical cannabis is licensed. Officers must articulate additional indicia of impairment.
That ruling does not directly govern the admissibility of DRE testimony. It does something arguably more useful for cannabis DUI defense: it attacks the front end of the encounter. If the officer's basis for extending the stop, ordering the defendant out of the vehicle, or initiating an SFST sequence is odor alone, the entire downstream record, including any DRE evaluation, may be subject to suppression. Defense counsel in jurisdictions with similar hemp and medical cannabis legalization frameworks have begun stacking Williams-style suppression motions on top of Moore-style Rule 702 challenges, attacking both the seizure and the expert opinion.
The Daubert and Kumho Playbook
Daubert and Kumho Tire gatekeeping applies to DRE testimony. The Supreme Court made clear in Kumho that the trial judge's reliability inquiry extends to technical or other specialized knowledge, not only to laboratory science. A DRE opinion is exactly that kind of testimony: an officer applying a published protocol to clinical-looking observations and reaching a categorical conclusion.
The defense playbook is now reasonably mature:
-
Attack the foundational validation studies. Bigelow, Compton, and Adler have well-documented methodological weaknesses including unblinded examiners and selection bias. The Forensic Resources DRE overview walks through these in detail.
-
Demand strict compliance with each of the 12 steps. A DRE who skipped pulse readings, omitted the darkroom pupil exam, or failed to take vital signs has not actually run the protocol that supposedly validates the opinion.
-
Cross-examine on the timing gap. Use NHTSA's own 90-minute peak-deficit lag and the greater than 80 percent THC decline to show the toxicology number is not what it appears to be.
-
Cross-examine on tolerance. Heavy and medical-cannabis users metabolize and respond differently. Peer-reviewed SFST studies in heavy users undermine the assumption that observed performance translates cleanly into impairment.
-
Use the Spring 2025 Cannabis Update from Forensic Resources to track the most recent rulings and identify analogous fact patterns.
Sample Motion-in-Limine Architecture
A defensible motion in limine against DRE testimony in a cannabis case generally includes four pillars:
-
Foundation challenge under Rule 702(a). Argue that the DRE protocol, as applied to cannabis, is not based on sufficient facts or data and is not the product of reliable principles and methods. Cite NHTSA's 2017 Report to Congress for the proposition that the prosecution's own federal authority does not endorse a meaningful per se THC level.
-
Personal-examination requirement under Rule 702(a)(3). Cite State v. Moore and demand that the testifying DRE be the officer who personally conducted the 12-step protocol on the defendant. Move to exclude any after-the-fact, video-only opinion.
-
Chain of custody on toxicology. Force the prosecution to establish the time of draw, the method of preservation, and the relationship between the blood level reported and the moment of driving.
-
Exclusion of category opinion. The DRE's ultimate opinion (the category of drug allegedly causing impairment) is the part with the weakest scientific footing. Move to exclude that opinion separately, even if the court admits descriptive observations like pulse and pupil size.
Subpoena the DRE face sheet and rolling log. Both documents are routinely generated as part of the 12-step process and routinely overlooked at trial. Discrepancies between them often appear once they are read side by side.
What Federal Rescheduling Does and Doesn't Change
On April 28, 2026, the Department of Justice and DEA issued a Final Order in the Federal Register placing FDA-approved marijuana products and marijuana products subject to a qualifying state-issued license in Schedule III. The DOJ announced the move the same day. Recreational, unlicensed, and synthetic THC remain in Schedule I. An expedited DEA administrative hearing on broader Schedule I to III rescheduling is set to run from June 29, 2026 through no later than July 15, 2026.
The scope of the April order is narrow and the legal commentary is unanimous on what it does not do. The Foley & Lardner practice alert and the Congressional Research Service Legal Sidebar LSB11105 both confirm that state DUI statutes are unaffected. Colorado's 5 ng/mL per se threshold remains in force. Illinois, Washington, Nevada, and Ohio per se and zero-tolerance frameworks remain in force. A defendant cannot walk into court in any of those states and argue that rescheduling has decriminalized impaired driving. It has not.
What rescheduling does change is the political and rhetorical environment in which trial judges are deciding Rule 702 motions. A judge who in 2022 might have viewed cannabis DUI as a straightforward enforcement priority is, in 2026, being asked to apply reliability gatekeeping to a substance that the federal executive branch has moved partway out of Schedule I. The pressure on the science is greater because the policy ground has shifted.
Practitioner Takeaways
File the motion in limine before jury selection, not at trial. Build the record with a written brief that attaches the NHTSA 2017 Report to Congress, the relevant peer-reviewed SFST studies, and the State v. Moore opinion. If your jurisdiction has its own appellate decision applying Rule 702 to DRE testimony, lead with that. If not, lead with Moore by analogy and the federal authorities.
Request an evidentiary hearing. Many trial courts will deny Rule 702 motions on the papers when they would grant relief, or at least narrow the testimony, after hearing the DRE on voir dire. The 12 steps have to be defended out loud. They often are not.
Subpoena the face sheet, the rolling log, the toxicology chain of custody, and any DRE certification renewal documents. Inconsistencies in those records are common and are not always self-evident in the prosecutor's file.
Track the jurisdictions that have shown the most receptiveness to Rule 702 challenges in 2025 and 2026. North Carolina is the obvious one after Moore. Florida is increasingly favorable on the front end of the stop after Williams. Other states are following.
Why 2026 Is a Hinge Year
For two decades, DRE testimony in cannabis cases moved through American courts with very little scrutiny. The combination of Schedule III politics, NHTSA's unresolved validation gap, and Moore-style appellate rulings is pushing trial courts to actually exercise the gatekeeping role they have always had on paper. The science has not changed. The willingness of judges to look at the science has.
For a defendant facing a cannabis DUI charge in 2026, that shift is the difference between a plea and a fight. The defense bar finally has a record to build on.
Related reading
Sources
-
NHTSA, Marijuana-Impaired Driving: A Report to Congress (DOT HS 812 440, July 2017)
-
UNC School of Government, State v. Moore: Some Foundation Required for DRE Testimony (Sept. 3, 2025)
-
NC Lawyers Weekly, Criminal Practice: Drug Recognition Expert Testimony (Aug. 12, 2025)
-
NC Office of Indigent Defense Services, Drug Recognition Experts Overview
-
Criminal Legal News, The Flawed Science of Cannabis Impairment Detection (Aug. 1, 2025)
-
Federal Register, Schedules of Controlled Substances: Rescheduling of Marijuana (April 28, 2026)
-
Congressional Research Service, Legal Consequences of Rescheduling Marijuana (LSB11105)
Note: This article contains AI-assisted content and has been reviewed by our editorial team.
IMPORTANT NOTICE: GavelDaily.com is an advertising and information service, not a law firm. Submitting this form does not create an attorney-client relationship. The information you provide will be shared with licensed criminal defense attorneys in your area who may contact you about your inquiry. All submissions are treated as confidential by our service, but attorney-client privilege does not attach until you formally retain an attorney. Any attorney you connect with through this service is independently responsible for their legal advice and representation. Free consultations are subject to individual attorney availability. If you are facing an immediate legal emergency, contact your local public defender's office or call 911.